Bone marrow-derived mononuclear cells (BMMNCs) + Granulocyte-colony stimulating factor (G-CSF) Combination Therapy

Bone marrow-derived mononuclear cells (BMMNCs) + granulocyte-colony stimulating factor (G-CSF) is a combination therapy approach used primarily in regenerative medicine. This treatment involves two key components: 1. **G-CSF Administration**: G-CSF is administered to mobilize stem cells from the bone marrow into peripheral circulation. It works by triggering cell changes within bone marrow, stimulating the production of neutrophils and other stem cells, and releasing them into the bloodstream[2][3]. 2. **BMMNC Collection and Transplantation**: Following G-CSF administration, bone marrow-derived mononuclear cells are harvested (typically via bone marrow aspiration), processed, and then administered to the patient, often through intracoronary injection or other targeted delivery methods[7][10]. The combination therapy has been investigated for various conditions, particularly cardiovascular diseases like myocardial infarction and dilated cardiomyopathy, as well as ischemic conditions and neurological disorders[3][4][6][7].

Other names

BMMNC + G-CSF